- Annual General Meeting of Kuros Biosciences approves all resolutions
- Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
- Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
- Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
- Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
More ▼
Key statistics
On Friday, Kuros Biosciences AG (KURN:SWX) closed at 7.50, -8.20% below its 52-week high of 8.17, set on Apr 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.44 |
---|---|
High | 7.88 |
Low | 7.40 |
Bid | 7.55 |
Offer | 7.45 |
Previous close | 7.54 |
Average volume | 266.98k |
---|---|
Shares outstanding | 36.87m |
Free float | 23.88m |
P/E (TTM) | -- |
Market cap | 277.97m CHF |
EPS (TTM) | -0.3697 CHF |
Data delayed at least 15 minutes, as of Apr 19 2024 16:30 BST.
More ▼